Macleods is one of the fastest growing pharmaceutical company, having strong presence in various therapeutics segments. Ranked amongst the top 10 companies.
Provide support at BR India within Discovery Sciences, focusing on small molecule lead identification and optimization in close collaboration with Novartis colleagues in the US and Switzerland, as well as Indian CROs, to discover and advance innovative therapies addressing areas of high unmet medical need.
Coordinate with cross-functional teams to ensure seamless integration of safety data into the overall drug development process. Monitor and evaluate adverse event reports to identify potential safety signals and trends.
Candidates having M.Sc. / M. Tech / M. Pharm. / M.V.Sc. or equivalent qualification in Life Sciences or allied subjects (Biochemistry / Biotechnology / Virology / Bioinformatics / Computational Biology / Microbiology, etc.)
M.Pharm / M.Sc. degree (with minimum 60% marks) in Medicinal Chemistry/Organic Chemistry / applied chemistry with hands- on experience in synthesis and characterization of heterocyclic compound.
The ICGEB SMART Fellowship programme promotes the mobility of researchers between ICGEB Member States as a way of enhancing skill development, acquisition of specific hands-on training in new technologies and increasing cooperation in science and technology and should provide clear evidence of strong collaboration between the two laboratories.
Masters degree in any field of Bioinformatics/Plant Molecular Biology/Life sciences/Biotechnology, or M.Tech degree in a related field with 2 years experience.
Post-graduate in Life Sciences (preferably Pharmacy) with minimum of 3 years pharmaceutical industry experience in regulatory affairs with proven track record and experience in health authority interactions and negotiations, end-to-end regulatory submissions